Skip to main content

Some Queries For Data Retrieval From StARlite

It is a public holiday in the UK today (we call these bank holidays, for reasons that seem obscure nowadays). The weather is traditionally bad on such days, and today is no exception, at least the remainder of the week, when we return to work, will be fine and sunny.

We will run a further StARlite schema and query walkthrough webinar shortly, but in the meantime here are some skeleton sql queries, that perform a set of related queries retrieving compounds/bioactivities for a given target. In this case the target is human PDE4A (for which the tid is 3), and human PDE5A (for which the tid is 276). We will walk through getting these unique target identifiers (or tids) on another occasion, but suffice it to say, that this is easy, especially programmatically, using blastp.

Firstly, retrieving a set of potent inhibitors of human PDE4A or PDE5A. There are a number of parameters one needs to set to actually do this (the end-point, the affinity cutoff, etc. Specifically here we have selected high confidence assay to target assignments (the a2t.confidence=7 bit), and where the potency is better than 1000nM for an IC50 measurement. This is a pretty generic query, and piping in the target tid to this covers a surprisingly frequent use the the data.

select  act.molregno, act.activity_type, act.relation as operator, act.standard_value, act.standard_units, 
   td.pref_name, td.organism, 
   a.description as assay_description, 
   docs.journal, docs.year, docs.volume, docs.first_page, docs.pubmed_id, cr.compound_key
from  target_dictionary td, 
   assay2target a2t,    
   assays a, 
   activities act, 
   docs, 
   compound_records cr
where  td.tid in (3,276)
and  td.tid = a2t.tid
and  a2t.confidence = 7
and  a2t.assay_id = a.assay_id
and  a2t.assay_id = act.assay_id
and  act.doc_id = docs.doc_id
and  act.record_id = cr.record_id
and  act.activity_type = 'IC50'
and  act.relation in( '=', '<')
and  act.standard_units = 'nM'
and  act.standard_value <=1000
and  a.assay_type = 'B';

Here is a modified form to retrieve just the compound identifiers (molregno)

select  distinct act.molregno
from  target_dictionary td, 
  assay2target a2t,    
  assays a,  
  activities act
where  td.tid in (3,276)
and  td.tid = a2t.tid
and  a2t.confidence = 7
and  a2t.assay_id = a.assay_id
and  a2t.assay_id = act.assay_id
and  act.activity_type = 'IC50'
and  act.relation in( '=', '<')
and  act.standard_units = 'nM'
and  act.standard_value <=1000
and  a.assay_type = 'B';

Also a common requirement is to get the associated molecule structures from the database - here the syntax is for an sdf format output and the query does not rely on any fancy chemical cartridge manipulation (since we store the molfiles in a clob called molfile in the COMPOUNDS table). The query here simply retrieves the structures, and not the associated bioactivity data. The goofy looking concatenations (||) and newlines (chr(10)) just make sure that a validly formatted sdf file emerges at the end.

select  c.molfile || chr(10) || '> ' ||chr(10)|| c.molregno||chr(10)||chr(10)||'$$$$'||chr(10)
from  compounds c, 
  (select distinct act.molregno
  from  target_dictionary td, 
    assay2target a2t,    
    assays a, 
   activities act
 where  td.tid in (3,276)
 and  td.tid = a2t.tid
 and  a2t.confidence = 7
 and  a2t.assay_id = a.assay_id
 and  a2t.assay_id = act.assay_id
 and  act.activity_type = 'IC50'
 and  act.relation in( '=', '<')
 and  act.standard_units = 'nM'
 and  act.standard_value <=1000
 and  a.assay_type = 'B') t1
where  t1.molregno = c.molregno;

Comments

Popular posts from this blog

Here's a nice Christmas gift - ChEMBL 35 is out!

Use your well-deserved Christmas holidays to spend time with your loved ones and explore the new release of ChEMBL 35!            This fresh release comes with a wealth of new data sets and some new data sources as well. Examples include a total of 14 datasets deposited by by the ASAP ( AI-driven Structure-enabled Antiviral Platform) project, a new NTD data se t by Aberystwyth University on anti-schistosome activity, nine new chemical probe data sets, and seven new data sets for the Chemogenomic library of the EUbOPEN project. We also inlcuded a few new fields that do impr ove the provenance and FAIRness of the data we host in ChEMBL:  1) A CONTACT field has been added to the DOCs table which should contain a contact profile of someone willing to be contacted about details of the dataset (ideally an ORCID ID; up to 3 contacts can be provided). 2) In an effort to provide more detailed information about the source of a deposited dat...

Improvements in SureChEMBL's chemistry search and adoption of RDKit

    Dear SureChEMBL users, If you frequently rely on our "chemistry search" feature, today brings great news! We’ve recently implemented a major update that makes your search experience faster than ever. What's New? Last week, we upgraded our structure search engine by aligning it with the core code base used in ChEMBL . This update allows SureChEMBL to leverage our FPSim2 Python package , returning results in approximately one second. The similarity search relies on 256-bit RDKit -calculated ECFP4 fingerprints, and a single instance requires approximately 1 GB of RAM to run. SureChEMBL’s FPSim2 file is not currently available for download, but we are considering generating it periodicaly and have created it once for you to try in Google Colab ! For substructure searches, we now also use an RDKit -based solution via SubstructLibrary , which returns results several times faster than our previous implementation. Additionally, structure search results are now sorted by...

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding ...

Improved querying for SureChEMBL

    Dear SureChEMBL users, Earlier this year we ran a survey to identify what you, the users, would like to see next in SureChEMBL. Thank you for offering your feedback! This gave us the opportunity to have some interesting discussions both internally and externally. While we can't publicly reveal precisely our plans for the coming months (everything will be delivered at the right time), we can at least say that improving the compound structure extraction quality is a priority. Unfortunately, the change won't happen overnight as reprocessing 167 millions patents takes a while. However, the good news is that the new generation of optical chemical structure recognition shows good performance, even for patent images! We hope we can share our results with you soon. So in the meantime, what are we doing? You may have noticed a few changes on the SureChEMBL main page. No more "Beta" flag since we consider the system to be stable enough (it does not mean that you will never ...

ChEMBL brings drug bioactivity data to the Protein Data Bank in Europe

In the quest to develop new drugs, understanding the 3D structure of molecules is crucial. Resources like the Protein Data Bank in Europe (PDBe) and the Cambridge Structural Database (CSD) provide these 3D blueprints for many biological molecules. However, researchers also need to know how these molecules interact with their biological target – their bioactivity. ChEMBL is a treasure trove of bioactivity data for countless drug-like molecules. It tells us how strongly a molecule binds to a target, how it affects a biological process, and even how it might be metabolized. But here's the catch: while ChEMBL provides extensive information on a molecule's activity and cross references to other data sources, it doesn't always tell us if a 3D structure is available for a specific drug-target complex. This can be a roadblock for researchers who need that structural information to design effective drugs. Therefore, connecting ChEMBL data with resources like PDBe and CSD is essen...